Search Results for "Sequitur Incorporated"
Original Source: Sequitur Incorporated
Sequitur, Inc. was founded in 1996 to develop innovative sequence-based compounds for functional genomics research, diagnostic and therapeutic applications. Sequitur's proprietary antisense technology can be employed to determine gene function and validate small molecule targets by specifically inhibiting gene expression. We also offer a line of products and services relating to gene expression and gene detection.
By Gary Schwitzer A paper published in Pediatrics, “Respiratory Tract Illnesses During the First Year of Life: Effect of Dog and Cat Contacts,” is getting lots of news attention, but most...
Matching PubMed Articles
Blanchard et al. (2009) demonstrated that hebephilia is a genuine sexual preference, but then proposed, without argument or evidence, that it should be designated as a mental disorder in the DSM-5. A...